Rampart Investment Management Company LLC increased its stake in shares of Agilent Technologies Inc (NYSE:A) by 26.3% during the second quarter, HoldingsChannel.com reports. The fund owned 28,467 shares of the medical research company’s stock after buying an additional 5,936 shares during the period. Rampart Investment Management Company LLC’s holdings in Agilent Technologies were worth $1,760,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. OppenheimerFunds Inc. boosted its holdings in shares of Agilent Technologies by 64.0% during the 2nd quarter. OppenheimerFunds Inc. now owns 7,636,621 shares of the medical research company’s stock worth $472,248,000 after buying an additional 2,980,216 shares during the period. Osterweis Capital Management Inc. bought a new stake in shares of Agilent Technologies during the 2nd quarter worth about $11,987,000. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Agilent Technologies by 257.3% during the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 260,100 shares of the medical research company’s stock worth $16,085,000 after buying an additional 187,300 shares during the period. Sandhill Capital Partners LLC bought a new stake in shares of Agilent Technologies during the 2nd quarter worth about $15,736,000. Finally, Advisors Capital Management LLC boosted its holdings in shares of Agilent Technologies by 1.5% during the 2nd quarter. Advisors Capital Management LLC now owns 51,891 shares of the medical research company’s stock worth $3,209,000 after buying an additional 759 shares during the period.

Several brokerages recently commented on A. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 target price for the company in a report on Tuesday, August 7th. Deutsche Bank lifted their target price on shares of Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, August 15th. ValuEngine downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, May 29th. Cowen raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating in a report on Tuesday, May 15th. Finally, Morgan Stanley lifted their target price on shares of Agilent Technologies from $83.00 to $84.00 and gave the stock an “overweight” rating in a report on Wednesday, August 15th. One analyst has rated the stock with a hold rating and nine have given a buy rating to the stock. Agilent Technologies presently has an average rating of “Buy” and a consensus target price of $75.67.

Shares of Agilent Technologies stock opened at $67.36 on Friday. Agilent Technologies Inc has a twelve month low of $60.42 and a twelve month high of $75.00. The company has a quick ratio of 2.88, a current ratio of 3.62 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $21.34 billion, a price-to-earnings ratio of 28.54, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, August 14th. The medical research company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.04. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The business had revenue of $1.20 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the previous year, the company earned $0.59 EPS. The business’s revenue was up 8.0% on a year-over-year basis. equities research analysts expect that Agilent Technologies Inc will post 2.71 EPS for the current fiscal year.

In other news, Director Boon Hwee Koh sold 6,931 shares of the business’s stock in a transaction that occurred on Tuesday, June 12th. The shares were sold at an average price of $66.38, for a total value of $460,079.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Using the New Google Finance Tool

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.